December 17, 2014 5:23 PM ET

Biotechnology

Company Overview of Invivoscribe Technologies, Inc.

Executive Profile

Mitchell Kronenberg Ph.D.

Chairman of Scientific Advisory Board and Director, Invivoscribe Technologies, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background

Dr. Mitchell Kronenberg, Ph.D serves as the President & Chief Scientific Officer at The La Jolla Institute for Allergy & Immunology. Dr. Kronenberg serves as Chairman of Scientific Advisory Board and Director at Invivoscribe Technologies, Inc. He has been a Member of the Scientific Advisory Board at Bio-Bridge Science Inc. since November 2008. He is a Deputy Editor for the Journal of Immunology. He serves on the Finance Committee of the American Association of Immunologists. ...

Corporate Headquarters

6330 Nancy Ridge Drive
San Diego, California 92121-3230

United States

Phone: 858-224-6600
Fax: 858-224-6601

Board Members Memberships

Chairman of Scientific Advisory Board and Director

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Invivoscribe Technologies, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.